NCT03542136View on ClinicalTrials.gov

Peripheral Neuropathy in Colorectal Cancer Patients Under Adjuvant Chemotherapy With FOLFOX, FLOX or XELOX Regime

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 4, 2018

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Colorectal Cancer
Interventions
DEVICE

VibrosSense Meter®

A multi frequency tactilometry device to evaluate the vibrotactile sense to indicate the underlying (Oxaliplatin induced poly neuropathy) OIPN and then compare the results with the results of CTCAE (Common toxicity criteria of adverse events) assessment tool evaluation.

Trial Locations (1)

221 85

Lund University Hospital, Lund

All Listed Sponsors
lead

Lund University Hospital

OTHER

NCT03542136 - Peripheral Neuropathy in Colorectal Cancer Patients Under Adjuvant Chemotherapy With FOLFOX, FLOX or XELOX Regime | Biotech Hunter | Biotech Hunter